Q&A: Advocating open source drugs
Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.
Science and Development Network
News, views and information about science, technology and the developing world
Here is a list of the latest articles
Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.
Bovine tuberculosis is no less dangerous to humans than common TB, but relatively little is known about it, reports Natasha Bolognesi.
Priya Shetty looks at the prevalence and distribution of tuberculosis in the developing world, outlining the truths — and myths — about this disease.
27 June 2007 | EN
Jill McGivering and Ed Cropley report on how fake drugs and poor education increase resistance to antimalarials in South-East Asia.
Source: BBC and Reuters
The division between global programmes to fight TB and HIV is undermining the fight against the two diseases — but there are signs of change, reports Apoorva Mandavilli.
Source: Nature Medicine
A WHO initiative aims to quantify the global burden of foodborne disease, says Arie Havelaar
Rapid diagnostic tests may present a quick and easy-to-use solution for improved malaria diagnosis